These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 20363045)

  • 1. stab: an R package for drug stability data analysis.
    Lee HY; Wu PC; Lee YJ
    Comput Methods Programs Biomed; 2010 Nov; 100(2):140-8. PubMed ID: 20363045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability testing requirements for vaccines--draft guidelines of the International Conference on Harmonization.
    Haase M
    Dev Biol Stand; 1996; 87():309-18. PubMed ID: 8854031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability analysis for drugs with multiple active ingredients.
    Chow SC; Shao J
    Stat Med; 2007 Mar; 26(7):1512-7. PubMed ID: 16955533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International Conference on Harmonisation; evaluation of stability data; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Jun; 69(110):32010-1. PubMed ID: 15185712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance levels for stability pooling test: a simulation study.
    Chen WJ; Tsong Y
    J Biopharm Stat; 2003 Aug; 13(3):355-74. PubMed ID: 12921387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine stability study design and analysis to support product licensure.
    Schofield TL
    Biologicals; 2009 Nov; 37(6):387-96; discussion 421-3. PubMed ID: 19717312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simulation study with statistical evaluation for the determination of non-isothermal kinetics conditions in drugs stability.
    Fernández de Aránguiz MY; de la Torre S; Berraondo MR
    Eur J Pharm Sci; 2007 Aug; 31(5):277-87. PubMed ID: 17540544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of degradant profiling in active pharmaceutical ingredients and drug products.
    Alsante KM; Ando A; Brown R; Ensing J; Hatajik TD; Kong W; Tsuda Y
    Adv Drug Deliv Rev; 2007 Jan; 59(1):29-37. PubMed ID: 17187892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability study of losartan/hydrochlorothiazide tablets.
    Lusina M; Cindrić T; Tomaić J; Peko M; Pozaić L; Musulin N
    Int J Pharm; 2005 Mar; 291(1-2):127-37. PubMed ID: 15707739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating Current Practices in Shelf Life Estimation.
    Capen R; Christopher D; Forenzo P; Huynh-Ba K; LeBlond D; Liu O; O'Neill J; Patterson N; Quinlan M; Rajagopalan R; Schwenke J; Stroup W
    AAPS PharmSciTech; 2018 Feb; 19(2):668-680. PubMed ID: 28948584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pooling data for stability studies: testing the equality of batch degradation slopes.
    Ruberg SJ; Stegeman JW
    Biometrics; 1991 Sep; 47(3):1059-69. PubMed ID: 1742430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a quality-by-design approach to justify removal of the HPLC weight % assay from routine API stability testing protocols.
    Skrdla PJ; Wang T; Antonucci V; Dowling T; Ge Z; Ellison D; Curran J; Mohan G; Wyvratt J
    J Pharm Biomed Anal; 2009 Dec; 50(5):794-6. PubMed ID: 19596534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equivalence tests for shelf life and average drug content in stability studies.
    Djira GD; Hothorn LA; Tsong Y
    J Biopharm Stat; 2008; 18(5):985-95. PubMed ID: 18781530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability studies of anticancer agent bis(4-fluorobenzyl)trisulfide and synthesis of related substances.
    Bao Y; Mo X; Xu X; He Y; Xu X; An H
    J Pharm Biomed Anal; 2008 Nov; 48(3):664-71. PubMed ID: 18678459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-phase shelf-life estimation.
    Shao J; Chow SC
    Stat Med; 2001 Apr; 20(8):1239-48. PubMed ID: 11304739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of bracketing and matrixing designs for a two-year stability study.
    Pong A; Raghavarao D
    J Biopharm Stat; 2000 May; 10(2):217-28. PubMed ID: 10803726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the distribution of batch shelf lives.
    Quinlan M; Stroup W; Christopher D; Schwenke J
    J Biopharm Stat; 2013; 23(4):897-920. PubMed ID: 23786624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of vaccines - bridging from stability data to continuous safety and efficacy throughout shelf life - an always reliable approach?
    Pfleiderer M
    Biologicals; 2009 Nov; 37(6):364-8. PubMed ID: 19773184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some considerations about stability study design.
    Repeto P
    J Biopharm Stat; 2000 Feb; 10(1):73-82. PubMed ID: 10709802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Shelf-life estimation of pharmaceutical products by matrixing].
    Yoshioka S; Aso Y; Kojima S
    Eisei Shikenjo Hokoku; 1996; (114):143-4. PubMed ID: 9037887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.